OBJECTIVE: To test the hypothesis that nicotine not only activates uncoupling protein1 (UCP1) in brown adipose tissue (BAT), but also induces UCP1 in white adipose tissue (WAT), which contributes to the mitigation of obesity in obese mice. DESIGN: Weights of the whole body, the gastrocnemius muscle, interscapular BAT and subcutaneous and retroperitoneal WAT, food intake and the mRNA and protein of UCP1 in these tissues were measured and immunohistochemistry using antiserum against UCP1 was also performed in obese yellow KK mice treated with nicotine for 6 months and control mice treated with physiological saline. RESULTS: Obese mice treated with nicotine for 6 months, compared with those injected with saline, weighed signi®cantly less (P`0.01) and had smaller subcutaneous and retroperitoneal WAT pads (P`0.01), while obese mice that received nicotine ate less (P`0.05) than those injected with saline. In mice treated with nicotine, the mRNA and protein of UCP1 was detected not only in BAT, but also in subcutaneous and retroperitoneal WATs. Immunohistochemically, the BAT of obese mice contained large lipid droplets and appeared rather WAT-like, but changed to typical brown adipocytes after nicotine treatment. The fat pads of nicotine-treated mice contained many multilocular cells that were positive for UCP1. CONCLUSION: Nicotine not only activates UCP1 in BAT, but also induces UCP1 in WAT and decreases food intake, which contributes to the mitigation of obesity.
Introduction
We have already shown that nicotine stimulates sympathetic nervous system activity and promotes thermogenesis in brown adipose tissue (BAT) and resting metabolic rate (RMR), all of which contribute to the mitigation of obesity. 1 ± 3 However, we recently found 4 ± 6 that a b 3 -adrenergic agonist induces a functionally active uncoupling protein1 (UCP1), a key molecule for metabolic thermogenesis, in adipose tissues conventionally considered white adipose tissue (WAT) and even in skeletal muscle. Therefore, in this study, we investigated the hypothesis that nicotine not only activates UCP1 in BAT, but also induces UCP1 in WAT, which contributes to the mitigation of obesity.
Methods
A total of 60 female obese yellow KK mice 4, 7 (Charles River Japan, Osaka) were obtained at the age of eight weeks and housed in plastic cages at 22 AE 2 C with 12 h light-dark cycle, and given free access to laboratory chow (CE-2; Clea Japan, Tokyo) and tap water. The animals were divided into two groups. One group was injected subcutaneously with nicotine 2, 3, 8 (Sigma Chemicals, St.Louis, MO) at a dose of 1.0 mgakg dissolved in physiological saline once daily for the ®rst 3 months and then at a dose of 1.2 mgakg once daily for the last 3 months. The control group was injected daily with physiological saline instead of nicotine. Food intake was measured, and, after 6 months, 15 mice in each group were weighed, and then killed by cervical dislocation. Skeletal muscle (gastrocnemius), interscapular BAT, and subcutaneous and retroperitoneal WATs were rapidly removed, weighed and frozen in liquid nitrogen for Western blot and Northern blot analyses. Fifteen other sets of these tissues were obtained and treated by the methods described below for immunohistochemistry. Animal care and procedures were approved by the Animal Care and Use Committee of Kyoto Prefectural University of Medicine.
Western blot analysis.
Each tissue (6 individual samples in each group) was homogenized in 5±10 volumes of a solution containing 10 mM Tris-HCl (Sigma, St. Louis, MO, USA) and 1 mM EDTA (pH7.4) (Sigma) for 30 s with a Polytron. After centrifugation at 1500Âg for 5 min, the fat cake was discarded, and the infranatant (fat-free extract) was used for Western blot analysis of UCP1 as described previously. 9, 10 Brie¯y, the fat-free extract (10 mg protein of BAT, 20 mg of WAT and 40 mg of muscle) was solubilised, subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) (Wako, Osaka, Japan), and transferred to a nitrocellulose ®lter (Wako). After the ®lter was blocked with 5% non-fat dry milk (Wako), it was incubated with a rabbit antiserum (Wako) (Â1000 diluted) against rat UCP1 puri®ed from interscapular BAT. 11 The ®lter was then incubated with [ 125 I]protein A (ICN, Irvine, CA, USA). The dry blot was exposed to an X-ray ®lm for autoradiography or an imaging plate of the BAS1000 system (Fuji Film, Tokyo, Japan) for quantitative analysis.
RNA analysis. Total RNA (6 individual samples in each group) was extracted from 0.1±1 g tissue using TRIzol (Gibco BRL, Tokyo) and the concentration determined from absorbance at 260 nm. Total RNA (20 mg from BAT, 40 mg from other tissue) was separated on a 1.0% agaroseaformaldehyde gel (Wako), and transferred to and ®xed on a nylon membrane. A 488 bp uncoupling protein1 cDNA probe corresponding to the coding region of rat UCP1 12 was prepared by digesting whole UCP1 cDNA (a gift from Dr D Ricquier, CNRS, Meudon, France) with BamHI, and labelled by random priming with [a-32 P]dCTP (ICN Irvine, CA, USA). The blots were hybridised to the labelled probe at 42 C for 20 h in the presence of 500 mgaml salmon sperm DNA (Wako), and exposed to an X-ray ®lm for autoradiography and a BAS1000 imaging plate (Fuji Film, Tokyo, Japan) for quantitative analysis.
Immunohistochemistry.
Fifteen mice each treated with nicotine or physiological saline were anaesthetised with diethyl ether and perfused transcardially with 4% paraformaldehyde in phosphate-buffered saline (PBS), and the subcutaneous and retroperitoneal fat pads and gastrocnemius muscle were removed and ®xed in Bouin solution. The ®xed tissues were dehydrated in ethanol, paraf®n-embedded, and cut into 7 mm-thick sections. The dewaxed sections were incubated in 0.3% hydrogen peroxide in methanol to inhibit endogenous peroxidase activity, and then with 10% normal goat serum, the rabbit antiserum against rat UCP1 (Â500 diluted), goat antirabbit IgG (Â400 diluted, Vector, Buringame, CA, USA), and ®nally with avidin-biotin-peroxidase complex (Vector Buringame, CA, USA) according to the conventional ABC method. The sections were also counterstained with hematoxylin and examined under a light microscope.
Data analysis. Data are presented as meansAE s.e.m. and analysed by ANOVA. Biochemical and histological analyses of UCP1 protein and mRNA were repeated using tissue samples obtained from 6 mice, and representative results are shown in the ®gures.
Results
Obese yellow KK mice with body weights of about 32 g were given nicotine or physiological saline once a day. After 6 months, the yellow KK mice treated with nicotine weighed signi®cantly less (51.6AE 1.2 vs 60.9AE 1.3 g, P`0.01) and had smaller WAT pads (4.57 AE 0.13 vs 7.35 AE 0.28 g for subcutaneous and retroperitoneal fat pads, P`0.01) than mice injected with saline. Nicotine treatment had no effects on the tissue weight of interscapular BAT (0.11 AE 0.03 vs 0.10AE 0.02 g) or gastrocnemius muscle (0.34 AE 0.04 vs 0.36 AE 0.05 g). Food intake of obese mice receiving nicotine was signi®cantly decreased compared to that of mice injected with saline (6.7 AE 0.3 vs 7.3 AE 0.3 gad, P`0.05).
As shown in Figure 1 , Northern blot analysis did not detect any UCP1 mRNA in any sample except BAT in mice given saline. In contrast, in mice treated with nicotine, a clear band smaller than 18S ribosomal RNA was detected more strongly not only in the BAT, but also in subcutaneous and retroperitoneal WATs (Figure 1 ). However, UCP1 mRNA band could not be detected in the gastrocnemius muscle. The approximate relative levels of UCP1 mRNA in WAT after nicotine treatment vs BAT in controls and after nicotine treatment were 12±14% and 8±10%, respectively. To determine whether the UCP1 protein is present not only in BAT but also in WAT and Figure 1 Northern blot analysis of UCP1 mRNA of fat pads and muscles. Obese yellow KK mice were given nicotine or physiological saline for 6 months, and the total RNA (20 mg from BAT, 40 mg from other tissues) was used for Northern blot analysis. The results are representative of 6 independent samples. BAT, brown adipose tissue; WAT, white adipose tissue.
Nicotine induces UCP1 in white fat T Yoshida et al muscle, a crude fat-free extract of the tissue was applied to Western blot analysis. As shown in Figure 2 , a clear protein band was detected at $ 33 kDa in subcutaneous and retroperitoneal WATs as well as in BAT of mice treated with nicotine. The molecular size of this protein was identical to a strong UCP1 signal present in BAT. However, UCP1 protein band could not be detected in the muscle. In contrast, in mice given saline, no band was detected in any tissue except BAT (Figure 2) . The approximate relative levels of UCP1 protein in WAT after nicotine treatment vs BAT in controls and after nicotine treatment were 25±45% and 9±17%, respectively.
The morphological characteristics of fat pads expressing UCP1 were examined immunohistochemically. Although BAT of yellow KK mice were occupied by multilocular cells containing large lipid droplets which appear rather WAT-like and were always positive for UCP1, nicotine treatment changed these cells to typical brown adipocytes (Figure 3) . Macroscopically, the fat pads of the nicotine-treated yellow KK mice were less pale than those of physiological saline-treated mice. Histochemically, many multilocular cells which were positive for UCP1 were contained not only in subcutaneous WAT (Figure 4 ), but also in retroperitoneal WAT (®gure not shown). Unilocular cells were also present in the fat pads but were always negative for UCP1, and their size was smaller than the typical unilocular cells found in saline-treated mice. Fat pads of saline-treated mice were mostly comprised of unilocular cells ®lled with a single large lipid droplet which were always negative for UCP1. Therefore the nicotine-treated mice had many typical brown adipocytes in fat pads Figure 2 Western blot analysis of UCP1. Mice were treated as described in Figure 1 , and fat-free extracts containing 10 mg protein of brown adipose tissue (BAT), 20 mg of white adipose tissue (WAT), and 40 mg of muscle were used for Western blot analysis. The results are representative of 6 independent samples. 
Nicotine induces UCP1 in white fat
T Yoshida et al usually considered WAT. However, the gastrocnemius muscle was negative for the UCP1 (data not shown).
Discussion
In this study, we used 1.0 mgakg during the ®rst 3 months and 1.2 mgakg during the last 3 months as the daily dose of nicotine, although 0.4 mgakg of nicotine was used as the optimal dose in previous experiments 2, 5, 8, 13 . This was because our preliminary experiments showed that nicotine administration at a daily dose of 0.4 mgakg for 6 months activated BAT function and slightly induced UCP1 mRNA in WAT, but did not promote UCP1 protein in WAT. Furthermore, nicotine at a daily dose of 1.0 mgakg for 6 months induced the expression of UCP1 mRNA in WAT, but did not suf®ciently induce the expression of UCP1 protein. Furthermore, we found that mice often died after injecting nicotine at a dose of 1.2 mgakg, but that mice receiving nicotine at a dose of 1.0 mgakg for 3 months, did not die after injecting nicotine at a dose of 1.2 mgakg. Therefore, the protocol of the present study was based on these preliminary studies: that is, nicotine administration at a daily dose of 1.0 mgakg for the ®rst 3 months and at a daily dose of 1.2 mgakg for the last 3 months. The present results showed that the chronic treatment of obese yellow KK mice with nicotine activated BAT and resulted in the signi®cant expression of UCP1 in the white fat pads (which are conventionally considered white adipose tissue), but not in skeletal muscle, which contributed to the mitigation of obesity with decreased food intake. However, several groups 14, 15 have recently cloned genes that encode novel uncoupling proteins UCP2 and UCP3, which have 59% and 57% amino-acid identity to the conventional UCP (UCP1), respectively. UCP2 is expressed in a wide variety of tissues, including adipose tissues, lung and skeletal muscle, while UCP3 is speci®c to BAT and skeletal muscle. Therefore, it may be possible that the UCP1 signals detected in tissues other than typical BAT are those of UCP2 and UCP3 rather than UCP1. However, this is unlikely, because: (a) a protein band of UCP1 in this study was detected at $ 33 kD in WAT of obese mice treated with nicotine. The molecular size of this protein was identical to that of a strong UCP1 signal present in BAT; (b) a clear band smaller than 18S ribosomal RNA was detected not only in BAT but also in WAT, suggesting that it is about 1.4 kb. As it is known that the mRNA size is 1.4 and 1.8 kb doublet for UCP1, 1.6 kb for UCP2 and 2.5 and 2.8 kb doublet for UCP3 in mice, 14, 15 the mRNA detected in this study did differ from mRNA for UCP3, although mRNA for UCP2 could not be distinguished; (c) in the present study, the signals of mRNA and protein were not detected in any tissues except BAT in the control animals without nicotine treatment; and (d) the ectopic signals were found only after the nicotine treatment.
Immunohistochemical examinations also showed that UCP1 expressing fat pads contained numerous multilocular cells indistinguishable from typical brown adipocytes. The fat pads contained many typical unilocular`white' fat cells, but they were always negative for UCP1 signals. Therefore, it was shown that nicotine administration resulted in the appearance of`brown' adipocytes expressing UCP1 in adipose Figure 4 Immunoistochemical detecction of UCP1 in white fat pads. Sections of a subcutaneous fat pad of an obese yellow KK mouse treated with nicotine (A) or physiological saline (B) were stained by rat UCP1 antibody (Â80) as described in Figure 3 . Arrows indicate multilocular cells.
Nicotine induces UCP1 in white fat T Yoshida et al deposits usually considered white fat. Our hypothesis that nicotine not only activates UCP1 in BAT, but also induces UCP1 in WAT, which contributes to the mitigation of obesity was proven.
The present ®ndings showing that nicotine activates BAT function and decreases body weight and food intake were consistent with previous observations. 2, 3, 8, 13, 16 A similar ectopic expression of UCP1 was also reported in various fat pads other than typical BAT, particularly in the fat depots of rat exposed to cold, 17 and those of rats, 6,18 mice, 4, 5 and dogs 19 treated with b 3 -adrenergic receptor agonist. However, whether the mechanism of the ectopic occurrence of UCP1 in WAT by nicotine is a direct action or indirect action via the secretion of catecholamines from adrenal glands 20 and sympathetic nerve endings, 2,3 is unclear. However, the origin of brown adipocytes in white fat could be explained principally by either the recruitment of new preadipocytes to the tissue or conversion of adipocyte phenotypes from white to brown. Although it is rather dif®cult to discriminate these two possibilities immediately, the result suggests that the classi®cation of white and brown adipose tissues is a matter of expedience but not absolute. The conversion of BAT to white fat has often been observed in various types of obese animals. 7, 21, 22 Therefore, further examinations are required to clarify this issue.
In this study, we could not detect UCP1 signals in skeletal muscle after nicotine treatment. It is unclear why nicotine induced ectopic expression of UCP1 in WAT, but not in skeletal muscle, although a b 3 -adrenergic agonist induced ectopic UCP1 signals in both WAT and skeletal muscle. 4, 5 This problem also remains to be resolved, although it may depend solely on the dosage of nicotine.
Conclusions
The present ®ndings showed that the approximate relative levels of UCP1 mRNA in WAT after nicotine treatment vs BAT in controls and after nicotine treatment were 12±14% and 8±10%, respectively. And the approximate relative levels of UCP1 protein in WAT after nicotine treatment vs BAT in controls and after nicotine treatment were 25±45% and 9±17%, respectively. However, it is dif®cult to evaluate the contribution of the ectopically expressed UCP1 in WAT to whole body thermogenesis from these data. We have already found 5 that UCP1 in WAT induced by a b 3 -adrenergic receptor agonist is functionally active. In such cases, 5 the approximate relative levels of UCP1 mRNA and protein in WAT after b 3 -adrenergic receptor agonist were almost the same as those in the present study with nicotine. In obese mice receiving b 3 -adrenergic receptor agonist, the total guanosine 5 H -diphosphate (GDP) binding in mitochondria in BAT and WAT could be expected to be estimated as $ 2,200 and 731 pmol, provided that the total weights of BAT and WAT in obese mice are $ 0.3 and 10 g, respectively. Although we did not measure GDP-binding in mitochondria in BAT and WAT of mice injected with nicotine in the present study, such a rough estimation in mice receiving b 3 -adrenergic receptor agonist suggests a signi®cant contribution of ectopically expressed UCP1 to increased energy expenditure and thereby to the anti-obesity effect of nicotine. Furthermore, since UCP2 and UCP3 were not investigated in this study, whether nicotine affected UCP2 and UCP3, and if so, the relative importance of UCP1, UCP2 and UCP3 induced by nicotine in regulatory thermogenesis, remain to be clari®ed.
